- Home
- HDL vs SPRY Comparison
HDL vs SPRY Comparison
Compare HDL & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HDL
- SPRY
- Stock Information
- Founded
- HDL 2016
- SPRY 2015
- Country
- HDL Singapore
- SPRY United States
- Employees
- HDL N/A
- SPRY N/A
- Industry
- HDL Restaurants
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- HDL Consumer Discretionary
- SPRY Health Care
- Exchange
- HDL Nasdaq
- SPRY Nasdaq
- Market Cap
- HDL 1.4B
- SPRY 1.1B
- IPO Year
- HDL 2024
- SPRY N/A
- Fundamental
- Price
- HDL $25.10
- SPRY $12.90
- Analyst Decision
- HDL
- SPRY Strong Buy
- Analyst Count
- HDL 0
- SPRY 4
- Target Price
- HDL N/A
- SPRY $26.00
- AVG Volume (30 Days)
- HDL 11.1K
- SPRY 1.4M
- Earning Date
- HDL 02-20-2025
- SPRY 03-20-2025
- Dividend Yield
- HDL N/A
- SPRY N/A
- EPS Growth
- HDL N/A
- SPRY N/A
- EPS
- HDL 0.09
- SPRY N/A
- Revenue
- HDL $759,894,000.00
- SPRY $2,568,000.00
- Revenue This Year
- HDL $18.96
- SPRY $67,363.34
- Revenue Next Year
- HDL $14.25
- SPRY $511.99
- P/E Ratio
- HDL $272.51
- SPRY N/A
- Revenue Growth
- HDL 16.09
- SPRY 8460.00
- 52 Week Low
- HDL $13.94
- SPRY $6.29
- 52 Week High
- HDL $30.00
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- HDL N/A
- SPRY 44.57
- Support Level
- HDL N/A
- SPRY $11.00
- Resistance Level
- HDL N/A
- SPRY $14.87
- Average True Range (ATR)
- HDL 0.00
- SPRY 0.95
- MACD
- HDL 0.00
- SPRY 0.04
- Stochastic Oscillator
- HDL 0.00
- SPRY 31.26
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.